No jump before earnings; Drop to $30? $25? $20? $Sideways?

Can't get back above 0 on MACD. Can't get back above 50 on Stoch RSI. TradingNewsNow claims an intrinsic value per share above $130. Results and Presentations seem to not be helping. I'd "like" to see $41/share, but $24/share might be more the direction of Nektar Therapeutics before a rebound. Continuing to watch sideways movements between $30-$37 in the meantime.

Not a broker, nor is this financial advice. I had Nektar hope in opioid replacements for pain therapy and immuno-oncology therapies. I guess they simply cannot beat cannabis in providing quality of life.

تم فتح الصفقة:

Lowered Position